EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants

Unterschiede im COPD-Management nach Behandlertyp: Erhaltungstherapie-Gewohnheiten und Patientenmerkmale bei US-Pneumolog:innen, Ärzt:innen für Innere/Allgemeinmedizin, Nurse Practitioners und Physician Assistants

Mario Castro, Kevin C Carney, Steven M Romanelli, Amy L Dixon, Maryam Q Abdul Rahman, Kavita Aggarwal, Barbara P Yawn

Chronic Respiratory Disease · 2025-04 · 22

DOI: 10.1177/14799731251346191 ↗

Auf einen Blick

Eine retrospektive Querschnittserhebung zeigte Unterschiede im COPD-Behandlungsverhalten zwischen US-Kliniker:innen. Innere/Allgemeinmedizin und NP/PA verschrieben häufiger LABA/ICS, Pneumolog:innen bevorzugten duale Bronchodilatation.

Fragestellung

Unterscheiden sich Patientenmerkmale und Behandlungsmuster bei COPD je nach Behandlertyp in den USA?

Methode

Retrospektive Querschnittserhebung mit aus Krankenakten abstrahierten Daten von COPD-Patient:innen durch Pneumolog:innen, Ärzt:innen für Innere/Allgemeinmedizin, NPs und PAs.

Ergebnisse

Daten zu 700 Patient:innen von 175 Kliniker:innen: 100 Pneumolog:innen, 45 Inner-/Allgemeinmediziner:innen, 30 NP/PA. 11 % mild, 51 % moderat, 38 % schwer/sehr schwer. Duale Therapien wurden je nach Behandlertyp unterschiedlich verordnet.

Schlussfolgerung der Autor:innen

Die Autor:innen berichten Unterschiede in den COPD-Behandlungsmustern zwischen US-Kliniker:innen. Trotz Erhaltungstherapie hatte COPD einen deutlichen Einfluss auf die Patient:innen; bessere Therapien seien nötig.

Kernaussagen

  • 700 Patient:innen aus 175 Kliniker:innen erfasst
  • LABA/ICS häufiger bei Inner-/Allgemeinmedizin und NP/PA
  • Pneumolog:innen bevorzugten duale Bronchodilatation

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Chronic Respiratory Disease, online erschienen am 05.06.2025. Verfasst von Mario Castro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Muscarinic Antagonists, Practice Patterns, Physicians', Bronchodilator Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Verona Pharma.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Treatment recommendations for chronic obstructive pulmonary disease (COPD) are based on single or combination long-acting bronchodilator therapy (β 2 -agonists [LABAs] or muscarinic receptor antagonists [LAMAs]), with inhaled corticosteroids (ICS) for those at risk of exacerbations. This study evaluated differences in patient characteristics and treatment patterns among US clinicians.

Methods

Medical record data for patients with COPD were abstracted via a retrospective cross-sectional survey by pulmonologists, internal/family medicine physicians, nurse practitioners (NPs) and physician assistants (PAs).

Results

Data on 700 patients were collected from 175 clinicians: 100 pulmonologists, 45 internal/family medicine physicians, 30 NP/PAs. Respondents classified patients as having Mild (11%), Moderate (51%), or Severe/Very Severe (38%) COPD, with highest perceived disease burden for patients with Severe/Very Severe COPD. Dual therapies were prescribed differently according to clinician type. Internal/family medicine physicians and NP/PAs prescribed LABA/ICS to a significantly higher proportion of patients than pulmonologists, who favored use of dual bronchodilator therapy. Regardless of clinician type, COPD management was complex, with patients starting and transitioning to multiple treatments throughout their care.

Conclusion

Differences in COPD treatment patterns exist across US clinicians. Despite current maintenance treatment, COPD had a profound impact on patients, indicating a need for improved therapies for COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMuscarinic AntagonistsPractice Patterns, Physicians'Bronchodilator AgentsAdrenergic beta-2 Receptor AgonistsAdrenal Cortex HormonesHumansMaleFemaleNurse PractitionersPhysician AssistantsCross-Sectional StudiesMiddle AgedRetrospective StudiesAgedUnited StatesPulmonologistsFamily PracticeDrug Therapy, CombinationInternal MedicinePhysicians, FamilyAdministration, InhalationSeverity of Illness Index

Stichwörter der Autor:innen

COPDmaintenance COPDtreatment journeytreatment patternstreatment switches

Substanzen

Muscarinic AntagonistsBronchodilator AgentsAdrenergic beta-2 Receptor AgonistsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • Department of Thoracic Medicine & Surgery, Temple University Hospital, Philadelphia, PA, USA.
  • Trinity Life Sciences, Waltham, MA, USA.
  • Medical Affairs, Verona Pharma, Raleigh, NC, USA.
  • Department of Family and Community Health, University of Minnesota, Minneapolis, MN, USA.

Förderung

  • Verona Pharma

Zitieren

APA

Castro, M., Carney, K. C., Romanelli, S. M., Dixon, A. L., Abdul Rahman, M. Q., Aggarwal, K., & Yawn, B. P. (2025). Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants. Chronic Respiratory Disease, 22. https://doi.org/10.1177/14799731251346191

Vancouver

Castro M, Carney KC, Romanelli SM, Dixon AL, Abdul Rahman MQ, Aggarwal K, et al. Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants. Chronic Respiratory Disease. 2025;22. doi:10.1177/14799731251346191

BibTeX
@article{Castro2025,
  author = {Castro, Mario and Carney, Kevin C and Romanelli, Steven M and Dixon, Amy L and Abdul Rahman, Maryam Q and Aggarwal, Kavita and Yawn, Barbara P},
  title = {Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants},
  journal = {Chronic Respiratory Disease},
  year = {2025},
  volume = {22},
  doi = {10.1177/14799731251346191}
}
Kostenlos starten →